Categories
Change Password!
Reset Password!
Updated clinical guidance highlights optimal treat...
Multi-strain probiotics as nutritional therapy for...
Chronic constipation is a common gastrointestinal disorder among middle-aged and older adults, often linked with reduced quality of life and limi...
Helicobacter pylori as a Reversible Cause of Treat...
Fidaxomicin
Fidaxomicin is a novel macrocyclic macrolide antibiotic and the first member of a new class of antimicrobial agents.
Omeprazole–domperidone combination delivers signif...
Acid peptic disease (APD) continues to impose a considerable gastrointestinal burden on patients with Type 2 diabetes mellitus (T2DM), with sympt...
New German S1 guideline updates diagnosis and trea...
Functional dyspepsia (FD), a common disorder of gut–brain interaction (DGBI), remains a common yet clinically challenging disorder because...
Why some GERD patients feel more heartburn than ot...
The relationship between esophageal acid exposure and symptom severity in gastroesophageal reflux disease (GERD) is often complex, with high leve...
Nitazoxanide-based regimens outperform standard tr...
A novel systematic review and meta-analysis of randomized controlled trials suggests that nitazoxanide (NTZ)-based triple therapy may offer super...
Persistent Belching in Functional Dyspepsia Succes...
Management strategies for small bowel obstruction...
Small bowel obstruction and no prior abdominal surgery (NPA-SBO) presents a complex clinical condition.
